Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meninges | 17 | 2023 | 198 | 5.030 |
Why?
|
| Nociceptors | 25 | 2021 | 461 | 4.600 |
Why?
|
| Post-Traumatic Headache | 7 | 2020 | 65 | 3.950 |
Why?
|
| Migraine Disorders | 24 | 2023 | 1701 | 3.210 |
Why?
|
| Dura Mater | 12 | 2023 | 290 | 2.850 |
Why?
|
| Cortical Spreading Depression | 8 | 2021 | 288 | 2.590 |
Why?
|
| Mast Cells | 13 | 2019 | 1392 | 2.210 |
Why?
|
| Hyperalgesia | 9 | 2020 | 531 | 1.760 |
Why?
|
| Rats, Sprague-Dawley | 36 | 2021 | 8181 | 1.370 |
Why?
|
| Trigeminal Nerve | 7 | 2018 | 248 | 1.300 |
Why?
|
| Pain Threshold | 5 | 2020 | 604 | 1.280 |
Why?
|
| Head Injuries, Closed | 3 | 2020 | 133 | 1.250 |
Why?
|
| Calcitonin Gene-Related Peptide | 6 | 2020 | 323 | 1.170 |
Why?
|
| Trigeminal Ganglion | 8 | 2014 | 190 | 1.100 |
Why?
|
| Pain | 13 | 2019 | 5073 | 1.000 |
Why?
|
| Neurons, Afferent | 5 | 2016 | 498 | 0.990 |
Why?
|
| Rats | 37 | 2021 | 23742 | 0.970 |
Why?
|
| Afferent Pathways | 5 | 2018 | 298 | 0.910 |
Why?
|
| Cell Degranulation | 3 | 2019 | 277 | 0.900 |
Why?
|
| Physical Stimulation | 12 | 2019 | 517 | 0.900 |
Why?
|
| Sumatriptan | 6 | 2016 | 66 | 0.830 |
Why?
|
| Cyclooxygenase 1 | 3 | 2012 | 97 | 0.780 |
Why?
|
| Brain Concussion | 3 | 2018 | 1404 | 0.760 |
Why?
|
| Tension-Type Headache | 2 | 2019 | 76 | 0.720 |
Why?
|
| Mechanoreceptors | 5 | 2011 | 188 | 0.690 |
Why?
|
| Serotonin Receptor Agonists | 5 | 2005 | 151 | 0.620 |
Why?
|
| Ophthalmic Nerve | 2 | 2018 | 42 | 0.610 |
Why?
|
| Nitric Oxide Synthase | 5 | 2001 | 908 | 0.580 |
Why?
|
| Trigeminal Neuralgia | 2 | 2017 | 107 | 0.570 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2016 | 31 | 0.550 |
Why?
|
| Sex Characteristics | 2 | 2020 | 2639 | 0.520 |
Why?
|
| Naproxen | 3 | 2018 | 100 | 0.510 |
Why?
|
| Touch Perception | 1 | 2016 | 107 | 0.500 |
Why?
|
| Craniocerebral Trauma | 1 | 2019 | 490 | 0.470 |
Why?
|
| Parietal Bone | 1 | 2014 | 49 | 0.460 |
Why?
|
| Animals | 51 | 2021 | 168459 | 0.460 |
Why?
|
| Frontal Bone | 1 | 2014 | 105 | 0.450 |
Why?
|
| Dinoprostone | 1 | 2016 | 597 | 0.440 |
Why?
|
| Periosteum | 1 | 2014 | 139 | 0.440 |
Why?
|
| Serotonin | 2 | 2016 | 1041 | 0.430 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 615 | 0.420 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2014 | 529 | 0.410 |
Why?
|
| Estrous Cycle | 1 | 2012 | 65 | 0.410 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 2005 | 710 | 0.400 |
Why?
|
| Trigeminal Caudal Nucleus | 1 | 2011 | 18 | 0.390 |
Why?
|
| Vasodilation | 2 | 2018 | 962 | 0.390 |
Why?
|
| Headache | 2 | 2023 | 1256 | 0.380 |
Why?
|
| Sciatic Nerve | 5 | 2001 | 617 | 0.370 |
Why?
|
| Action Potentials | 7 | 2011 | 1834 | 0.360 |
Why?
|
| Cyclooxygenase 2 | 2 | 2012 | 597 | 0.350 |
Why?
|
| Migraine without Aura | 1 | 2011 | 82 | 0.350 |
Why?
|
| Frontal Lobe | 1 | 2016 | 1420 | 0.350 |
Why?
|
| Neck Pain | 1 | 2011 | 190 | 0.340 |
Why?
|
| Adaptation, Physiological | 2 | 2015 | 1301 | 0.330 |
Why?
|
| Mastocytosis | 1 | 2011 | 150 | 0.330 |
Why?
|
| Electrophysiology | 7 | 2014 | 1262 | 0.330 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2008 | 361 | 0.320 |
Why?
|
| Receptor, PAR-2 | 1 | 2008 | 33 | 0.300 |
Why?
|
| Brain | 7 | 2023 | 27112 | 0.300 |
Why?
|
| Nerve Regeneration | 2 | 2005 | 795 | 0.290 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 687 | 0.290 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 654 | 0.290 |
Why?
|
| Nitric Oxide | 3 | 2005 | 2135 | 0.280 |
Why?
|
| Mice, Inbred ICR | 3 | 2019 | 364 | 0.280 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 490 | 0.270 |
Why?
|
| Brain Injuries | 1 | 2018 | 2053 | 0.270 |
Why?
|
| Neuronal Plasticity | 1 | 2015 | 1436 | 0.270 |
Why?
|
| Inflammation | 7 | 2018 | 10773 | 0.260 |
Why?
|
| Arteries | 1 | 2011 | 1123 | 0.260 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 999 | 0.260 |
Why?
|
| Sensory Receptor Cells | 1 | 2010 | 513 | 0.260 |
Why?
|
| Estrogens | 1 | 2012 | 1522 | 0.250 |
Why?
|
| Wallerian Degeneration | 2 | 2005 | 68 | 0.250 |
Why?
|
| Behavior, Animal | 3 | 2020 | 1878 | 0.240 |
Why?
|
| Male | 40 | 2020 | 360804 | 0.240 |
Why?
|
| Peripheral Nerves | 2 | 2005 | 479 | 0.220 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 18252 | 0.210 |
Why?
|
| Low Back Pain | 1 | 2011 | 984 | 0.210 |
Why?
|
| Cyclic GMP | 1 | 2004 | 395 | 0.210 |
Why?
|
| Membrane Proteins | 2 | 2010 | 7856 | 0.210 |
Why?
|
| Skull | 2 | 2019 | 818 | 0.210 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3208 | 0.190 |
Why?
|
| Vasodilator Agents | 1 | 2005 | 973 | 0.190 |
Why?
|
| Second Messenger Systems | 1 | 2002 | 202 | 0.190 |
Why?
|
| Receptors, Bradykinin | 1 | 2000 | 19 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2012 | 256 | 0.180 |
Why?
|
| Bradykinin | 1 | 2000 | 208 | 0.170 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 2 | 2011 | 41 | 0.170 |
Why?
|
| Neurons | 5 | 2016 | 9463 | 0.170 |
Why?
|
| Trigeminal Nucleus, Spinal | 2 | 2011 | 21 | 0.170 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 484 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 857 | 0.160 |
Why?
|
| Posterior Horn Cells | 2 | 2011 | 91 | 0.160 |
Why?
|
| Nitric Oxide Donors | 2 | 2013 | 125 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4352 | 0.160 |
Why?
|
| Autonomic Fibers, Postganglionic | 1 | 2018 | 5 | 0.160 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2019 | 137 | 0.160 |
Why?
|
| Cromakalim | 1 | 2018 | 22 | 0.160 |
Why?
|
| Microelectrodes | 2 | 2016 | 306 | 0.150 |
Why?
|
| KATP Channels | 1 | 2018 | 48 | 0.150 |
Why?
|
| Cyclic AMP | 1 | 2002 | 1463 | 0.150 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2018 | 108 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2011 | 586 | 0.140 |
Why?
|
| Pain Measurement | 3 | 2014 | 3550 | 0.130 |
Why?
|
| Axons | 1 | 2004 | 1674 | 0.130 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 462 | 0.130 |
Why?
|
| Neurotoxins | 2 | 2014 | 240 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 3 | 2018 | 2727 | 0.120 |
Why?
|
| Capillary Permeability | 1 | 2018 | 773 | 0.120 |
Why?
|
| Intracranial Pressure | 1 | 2016 | 324 | 0.120 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2000 | 952 | 0.120 |
Why?
|
| Permeability | 1 | 2016 | 723 | 0.120 |
Why?
|
| Functional Laterality | 2 | 2014 | 2257 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2001 | 517 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 2273 | 0.110 |
Why?
|
| Astrocytes | 1 | 2021 | 1346 | 0.110 |
Why?
|
| Enzyme Inhibitors | 4 | 2010 | 3712 | 0.110 |
Why?
|
| Sensory Thresholds | 2 | 2005 | 377 | 0.100 |
Why?
|
| Neural Conduction | 2 | 2005 | 441 | 0.100 |
Why?
|
| Constriction, Pathologic | 3 | 2001 | 1096 | 0.100 |
Why?
|
| Tamoxifen | 1 | 1997 | 965 | 0.100 |
Why?
|
| Hindlimb | 1 | 2014 | 513 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 307 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2009 | 705 | 0.100 |
Why?
|
| Blast Injuries | 1 | 2015 | 322 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2112 | 0.100 |
Why?
|
| Ergotamine | 1 | 2011 | 7 | 0.100 |
Why?
|
| Macrophages | 3 | 2018 | 5769 | 0.100 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1866 | 0.100 |
Why?
|
| Neuralgia | 1 | 1998 | 615 | 0.090 |
Why?
|
| Calcium | 1 | 2004 | 5722 | 0.090 |
Why?
|
| Antibodies | 1 | 2019 | 2418 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2000 | 12795 | 0.090 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2014 | 237 | 0.090 |
Why?
|
| Regional Blood Flow | 3 | 2005 | 1496 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2012 | 344 | 0.090 |
Why?
|
| Ovariectomy | 1 | 2012 | 614 | 0.090 |
Why?
|
| Analgesics | 1 | 2016 | 1070 | 0.080 |
Why?
|
| Middle Cerebral Artery | 1 | 2011 | 275 | 0.080 |
Why?
|
| Ectodysplasins | 1 | 2009 | 11 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2000 | 1666 | 0.080 |
Why?
|
| Mice | 6 | 2019 | 81525 | 0.080 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2011 | 281 | 0.080 |
Why?
|
| Touch | 1 | 2011 | 313 | 0.080 |
Why?
|
| Alcoholic Intoxication | 1 | 2010 | 174 | 0.080 |
Why?
|
| Military Personnel | 1 | 2018 | 1246 | 0.080 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2000 | 260 | 0.080 |
Why?
|
| Pia Mater | 1 | 2009 | 87 | 0.080 |
Why?
|
| Parasympathetic Nervous System | 1 | 2009 | 142 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1997 | 1520 | 0.080 |
Why?
|
| Time Factors | 7 | 2010 | 39967 | 0.080 |
Why?
|
| Nitrobenzenes | 1 | 2008 | 66 | 0.080 |
Why?
|
| Vasoconstriction | 1 | 2011 | 592 | 0.080 |
Why?
|
| Vimentin | 1 | 2009 | 255 | 0.080 |
Why?
|
| Humans | 18 | 2023 | 761504 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2004 | 11076 | 0.070 |
Why?
|
| Prostaglandin D2 | 1 | 2007 | 108 | 0.070 |
Why?
|
| Leukotriene C4 | 1 | 2007 | 79 | 0.070 |
Why?
|
| Spleen | 1 | 2012 | 2295 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2008 | 2219 | 0.070 |
Why?
|
| Epoprostenol | 1 | 2007 | 247 | 0.070 |
Why?
|
| Administration, Topical | 1 | 2008 | 704 | 0.060 |
Why?
|
| Reaction Time | 2 | 2005 | 2082 | 0.060 |
Why?
|
| Blood Vessels | 2 | 2009 | 1113 | 0.060 |
Why?
|
| Histamine | 1 | 2007 | 499 | 0.060 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2005 | 239 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2009 | 23445 | 0.060 |
Why?
|
| Ketorolac | 1 | 2005 | 94 | 0.060 |
Why?
|
| Imidazoles | 1 | 2010 | 1180 | 0.060 |
Why?
|
| Thionucleotides | 1 | 2004 | 112 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 1432 | 0.060 |
Why?
|
| Oxadiazoles | 1 | 2004 | 94 | 0.060 |
Why?
|
| Carbocyanines | 1 | 2004 | 175 | 0.060 |
Why?
|
| Nitroprusside | 1 | 2004 | 272 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 10766 | 0.060 |
Why?
|
| Hot Temperature | 2 | 2000 | 1440 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2004 | 205 | 0.050 |
Why?
|
| Denervation | 2 | 2001 | 265 | 0.050 |
Why?
|
| Visual Cortex | 1 | 2010 | 1107 | 0.050 |
Why?
|
| Bucladesine | 1 | 2002 | 118 | 0.050 |
Why?
|
| Differential Threshold | 1 | 2002 | 80 | 0.050 |
Why?
|
| Quinoxalines | 1 | 2004 | 296 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 1674 | 0.050 |
Why?
|
| Models, Biological | 1 | 2018 | 9469 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2010 | 1767 | 0.050 |
Why?
|
| Phenotype | 1 | 2019 | 16591 | 0.050 |
Why?
|
| Diabetic Neuropathies | 1 | 2005 | 405 | 0.050 |
Why?
|
| Nerve Crush | 1 | 2001 | 77 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2005 | 653 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1090 | 0.050 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2000 | 11 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2561 | 0.050 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2000 | 24 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10194 | 0.040 |
Why?
|
| Nerve Endings | 1 | 2000 | 105 | 0.040 |
Why?
|
| Anesthesia | 1 | 2011 | 1594 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2010 | 2009 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2004 | 590 | 0.040 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2019 | 29 | 0.040 |
Why?
|
| Glycerides | 1 | 2019 | 67 | 0.040 |
Why?
|
| Axonal Transport | 1 | 2000 | 178 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9177 | 0.040 |
Why?
|
| Female | 6 | 2020 | 392644 | 0.040 |
Why?
|
| Arachidonic Acids | 1 | 2019 | 294 | 0.040 |
Why?
|
| Endocannabinoids | 1 | 2019 | 111 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 2000 | 293 | 0.040 |
Why?
|
| Pyridines | 1 | 2010 | 2875 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2004 | 1038 | 0.040 |
Why?
|
| Schwann Cells | 1 | 1999 | 197 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2008 | 1978 | 0.040 |
Why?
|
| Nerve Net | 1 | 2010 | 2290 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2005 | 1336 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2004 | 2048 | 0.040 |
Why?
|
| Wounds and Injuries | 2 | 2001 | 2491 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 1998 | 361 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3548 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2000 | 526 | 0.040 |
Why?
|
| Guanidines | 1 | 1998 | 194 | 0.040 |
Why?
|
| Adult | 4 | 2019 | 221177 | 0.040 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 1997 | 48 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2006 | 1171 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 1903 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2007 | 8320 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3597 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2002 | 2707 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 1171 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14414 | 0.030 |
Why?
|
| Blotting, Western | 2 | 1999 | 5035 | 0.030 |
Why?
|
| Risk Factors | 2 | 2012 | 74206 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 1886 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 2011 | 306 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 59243 | 0.020 |
Why?
|
| Middle Aged | 3 | 2019 | 220895 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2010 | 230 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1997 | 21012 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1997 | 2767 | 0.020 |
Why?
|
| Migraine with Aura | 1 | 2010 | 204 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 1997 | 1366 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 15842 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1999 | 4414 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2850 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 397 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2010 | 1736 | 0.020 |
Why?
|
| Indomethacin | 1 | 2005 | 325 | 0.010 |
Why?
|
| Benchmarking | 1 | 2010 | 1045 | 0.010 |
Why?
|
| Logistic Models | 1 | 1998 | 13255 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 22169 | 0.010 |
Why?
|
| Skin | 2 | 2007 | 4484 | 0.010 |
Why?
|
| Adolescent | 2 | 2005 | 88319 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 1999 | 174 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2011 | 6630 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2010 | 3429 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 64680 | 0.000 |
Why?
|
Concepts
(253)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_